Proton-driven transformable nanovaccine for cancer immunotherapy N Gong, Y Zhang, X Teng, Y Wang, S Huo, G Qing, Q Ni, X Li, J Wang, ... Nature nanotechnology 15 (12), 1053-1064, 2020 | 221 | 2020 |
Aggregation-induced emission (AIE) fluorophores as imaging tools to trace the biological fate of nano-based drug delivery systems Y Wang, Y Zhang, J Wang, XJ Liang Advanced drug delivery reviews 143, 161-176, 2019 | 107 | 2019 |
Nanoscale drug delivery systems for controllable drug behaviors by multi-stage barrier penetration J Wang, Q Ni, Y Wang, Y Zhang, H He, D Gao, X Ma, XJ Liang Journal of Controlled Release 331, 282-295, 2021 | 78 | 2021 |
An amphiphilic dendrimer as a light-activable immunological adjuvant for in situ cancer vaccination Y Wang, N Gong, C Ma, Y Zhang, H Tan, G Qing, J Zhang, Y Wang, ... Nature Communications 12 (1), 4964, 2021 | 57 | 2021 |
Effect of physicochemical properties on in vivo fate of nanoparticle-based cancer immunotherapies Y Wang, J Wang, D Zhu, Y Wang, G Qing, Y Zhang, X Liu, XJ Liang Acta Pharmaceutica Sinica B 11 (4), 886-902, 2021 | 50 | 2021 |
Functionalized macrophage exosomes with panobinostat and PPM1D‐siRNA for diffuse intrinsic pontine gliomas therapy S Shan, J Chen, Y Sun, Y Wang, B Xia, H Tan, C Pan, G Gu, J Zhong, ... Advanced Science 9 (21), 2200353, 2022 | 48 | 2022 |
Improved pharmaceutical research and development with AIE-based nanostructures Y Zhang, Y Wang, J Wang, XJ Liang Materials Horizons 5 (5), 799-812, 2018 | 21 | 2018 |
DNA Damage Inducer Mitoxantrone Amplifies Synergistic Mild‐Photothermal Chemotherapy for TNBC via Decreasing Heat Shock Protein 70 Expression Z Chen, S Li, F Li, C Qin, X Li, G Qing, J Wang, B Xia, F Zhang, L Meng, ... Advanced Science 10 (16), 2206707, 2023 | 15 | 2023 |
Suppression of cytokine release syndrome during CAR-T-cell therapy via a subcutaneously injected interleukin-6-adsorbing hydrogel X Li, N Gong, F Tian, S Zhang, Y Zhang, Y Wang, G Qing, Y Wang, F Li, ... Nature Biomedical Engineering 7 (9), 1129-1141, 2023 | 13 | 2023 |
Targeted nanoparticles for precise cancer therapy J Wang, Y Wang, R Wang, S Zhang, X Liu, XJ Liang Science China. Life sciences 62 (10), 1392-1395, 2019 | 9 | 2019 |
Antibody-sheltered immunological nanonut (AINUT) for rheumatoid arthritis-targeted efficient alleviation L Liu, Y Zhang, C Mao, H Chen, Y Zhang, J Wang, C Fu, X Lan, W Wang, ... Nano Today 47, 101640, 2022 | 7 | 2022 |
Lipid-based intelligent vehicle capabilitized with physical and physiological activation F Zhang, B Xia, J Sun, Y Wang, J Wang, F Xu, J Chen, M Lu, X Yao, ... Research, 2022 | 6 | 2022 |
Conformation dependent architectures of assembled antimicrobial peptides with enhanced antimicrobial ability X Lan, J Zhong, R Huang, Y Liu, X Ma, X Li, D Zhao, G Qing, Y Zhang, ... Advanced Healthcare Materials 12 (29), 2301688, 2023 | 5 | 2023 |
Bone-Targeted dual functional lipid-coated drug delivery system for osteosarcoma therapy J Zhong, W Wen, J Wang, M Zhang, Y Jia, X Ma, Y Su, Y Wang, X Lan Pharmaceutical Research 40 (1), 231-243, 2023 | 5 | 2023 |
Navigations of the targeting pathway of nanomedicines toward tumor Y Tao, X Lan, Y Zhang, G Qing, J Wang, Y Xiao, H Chen, L Liu, XJ Liang, ... Expert Opinion on Drug Delivery 19 (8), 985-996, 2022 | 2 | 2022 |
T lymphocyte-derived immunogenic hybrid nanovesicles for immunosuppression reversion and boosted photothermal immunotherapy J Liu, Q You, S Ye, JJ Wang, R Du, F Liang, Z He, C Wang, L Zhu, Y Yang Nano Today 55, 102148, 2024 | | 2024 |
The Strategies of Nanomaterials for Drug Delivery and Release J Wang, Q Huang, XJ Liang Nanomedicine in Brain Diseases: Principles and Application, 59-82, 2019 | | 2019 |